Welcome to Macroaxis
Sign in to go to your portfolios
Don't have an account? Create It
  Macroaxis: Personalized Investing   The proven technology to invest wisely
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
  
 
US Market Closed: May 26, 04:02 AM 2012  
VRX ELN HSP ALKS PETS ACUR 
 
 
  NYSE  7,534  18.032  Index Moved Down 



Processing
Collecting data for FLML

Flamel management performance

    
    

Flamel Technologies SA

 Stock@American Stock Exchange 
United States
    
Use Flamel Technologies SA management performance concurrently with your other holdings to enhance returns of your portfolios and to back test it against optimization strategy that fits your risk preferences.
    
    

Flamel Management Effectiveness

The company has return on total asset (ROA) of (8.32) % which means that it has lost $8.32 on every $1 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.55) % meaning that it created substantial loss on money invested by shareholders.

Flamel Profit Margins

The company has Profit Margin (PM) of (25.65) % which may suggest that it does not properly executes on its current pricing strategies or is unable to controls all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (22.05) % which suggests for every dolor of sales it generated a net operating loss of -0.22.

Flamel Insiders

    
Michael Anderson CEO
Stephen Willard CEO and Member of Board of Directors
Mike Anderson CEO
Elie Vannier Non-Executive Independent Chairman of the Board
Rafael Jorda COO, Executive Vice President
Jean Chatellier Vice President - Alliance Management, Ph.D
Raphael Jorda COO and Executive VP
Charles Mosseri-Marlio Director of Strategic Planning and Investor Relations
John Vogelstein Independent Director
Martine Capelle Human Resources Director
You-Ping Chan Director - Chemistry Department And Analysis, Ph.D
Guillaume Cerutti Director
David Weber Supply Chain Director
Roger Kravtzoff Preclinical and Early Clinical Development Director, Ph.D
Francis Fildes Independent Director, Ph.D
Christian Kalita Chief Pharmacist and Director of Quality Assurance and Regulatory Affairs
Lodewijk Vink Independent Director
Craig Stapleton Director, MBA
Catherine Brechignac Director, Ph.D
Remi Meyrueix Director - Physico-Chemistry, Ph.D
Catherine Castan Director - Micropump Platform (Oral Drugs) and Intellectual Property, Ph.D
Yves Bourboulou Industrial Director, Director - Manufacturing Facility
Nigel McWilliam VP of Bus. Devel.
M Crouzet Principal Financial Officer and Financial Controller
Raphaelle Portella French Legal in-house Counsel
Sian Crouzet Principal Financial Officer
    

Flamel Technologies SA Workforce

    
Flamel Technologies SA is rated # 5 in number of employees category among related companies. The total workforce of Drug Delivery industry is currently estimated at about 24,221. Flamel claims roughly 267 in number of employees contributing just under 2% to equities under Drug Delivery industry.
    
    
Michael Anderson  CEO
CEO
Mr. Michael S. Anderson is Chief Executive Officer of Flamel Technologies SA., March 13, 2012. He has also served as Chief Executive Officer of ?clat Pharmaceuticals LLC since its formation in November 2010. ...
Stephen Willard  CEO
CEO and Member of Board of Directors
Mr. Stephen H. Willard is Director of Flamel Technologies SA. He is Director since 2001. Prior to being asked to serve as CEO by the Board of Directors in June of 2005, Mr. Willard was the Company?s Chief Financial Offic...
    

Tenure Analysis

Flamel employes about 267 people. The company is managed by 26 executives with total tenure of roughly 80 years, averanging almost 3.0 years of service per executive having 10.0 employee per reported executive.

Return on Flamel Manpower

Revenue Per Employee 124.2 K
Revenue Per Executive 1.3 M
Net Loss Per Employee 31.9 K
Net Loss Per Executive 327.3 K
Working Capital Per Employee 97.2 K
Working Capital Per Executive 997.7 K

Flamel Earnings Per Share

According to company disclosure Flamel Technologies SA has Earnings Per Share of -0.35 times. This is 133.02% lower than that of Healthcare sector, and 167.31% lower than that of Drug Delivery industry, The Earnings Per Share for all stocks is 123.65% higher than the company.
Earnings per Share is one of the most important measures of current share price of a firm, and is used by investors to determine company overall profitability especially when it is compared to EPS of similar companies.

Discuss Flamel

    
    



 

 
Analytics
Investor Landscape
Efficient Frontier
Market Correlation
Risk and Return Analysis
Financial Content
Portfolio Projections
Portfolio Backtesting
Tools
FAQs
Retirement Optimizer
RSS and Mobile Access
Company Directory
Advisor Directory
Insider Directory
Wealth Management
About Us
About Macroaxis
Contact Us
Terms Of Use
Privacy Policy
Custom Reporting
Product Tour
More ROI Custom Reporting